UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Vanguard Morningstar Large-Cap ETF
VV
$54.1B
| $2.1M | ﹤0.01% |
22,108
+269
| +1% | +$26K |
|
|
NATI
1327
DELISTED
National Instruments Corp
NATI
| $2.09M | ﹤0.01% |
71,006
+11,314
| +19% | +$348K |
|
|
SF
1328
Stifel
SF
$12.8B
| $2.09M | ﹤0.01% |
81,425
+8,775
| +12% | +$216K |
|
1329
Halozyme
HALO
$9.91B
| $2.09M | ﹤0.01% |
92,461
+51,965
| +128% | +$913K |
|
|
HRC
1330
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $2.08M | ﹤0.01% |
38,367
+3,600
| +10% | +$187K |
|
1331
Dillards
DDS
$9.63B
| $2.08M | ﹤0.01% |
19,818
+1,100
| +6% | +$135K |
|
|
P
1332
DELISTED
Pandora Media Inc
P
| $2.08M | ﹤0.01% |
134,078
+12,400
| +10% | +$218K |
|
1333
Wingstop
WING
$3.37B
| $2.08M | ﹤0.01% |
+73,304
| New | +$2.11M |
|
|
CSG
1334
DELISTED
CHAMBERS STR PPTYS COM
CSG
| $2.07M | ﹤0.01% |
260,210
+17,615
| +7% | +$137K |
|
|
SIR
1335
DELISTED
SELECT INCOME REIT
SIR
| $2.06M | ﹤0.01% |
227,564
+47,068
| +26% | +$482K |
|
1336
Radian Group
RDN
$5.21B
| $2.06M | ﹤0.01% |
109,994
+10,800
| +11% | +$194K |
|
1337
Jack in the Box
JACK
$351M
| $2.06M | ﹤0.01% |
23,399
+1,500
| +7% | +$135K |
|
1338
Outfront Media
OUT
$5.64B
| $2.06M | ﹤0.01% |
82,932
+9,042
| +12% | +$249K |
|
|
BOJA
1339
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $2.06M | ﹤0.01% |
+86,300
| New | +$2.18M |
|
1340
Curtiss-Wright
CW
$27.6B
| $2.06M | ﹤0.01% |
28,391
+2,400
| +9% | +$177K |
|
|
AAT
1341
American Assets Trust
AAT
$1.42B
| $2.05M | ﹤0.01% |
52,314
-2,605
| -5% | -$106K |
|
|
MSO
1342
DELISTED
MARTHA STEWART LIVING OMNIMEDIA INC
MSO
| $2.05M | ﹤0.01% |
328,682
-3,507
| -1% | -$19.8K |
|
1343
PBF Energy
PBF
$7.25B
| $2.05M | ﹤0.01% |
72,041
+9,300
| +15% | +$261K |
|
|
VIVO
1344
DELISTED
Meridian Bioscience Inc
VIVO
| $2.05M | ﹤0.01% |
109,788
+93,389
| +569% | +$1.73M |
|
|
RCAP
1345
DELISTED
RCS CAPITAL CORPORATION CLASS A COM
RCAP
| $2.04M | ﹤0.01% |
266,069
+105,772
| +66% | +$858K |
|
|
ENZ
1346
DELISTED
Enzo Biochem, Inc.
ENZ
| $2.03M | ﹤0.01% |
670,770
+299,278
| +81% | +$841K |
|
1347
Element Solutions
ESI
$9.34B
| $2.03M | ﹤0.01% |
79,226
+15,197
| +24% | +$410K |
|
1348
Glaukos
GKOS
$10.1B
| $2.02M | ﹤0.01% |
+69,700
| New | +$2.02M |
|
|
INVX
1349
Innovex International
INVX
$2.13B
| $2M | ﹤0.01% |
26,609
+2,300
| +9% | +$173K |
|
1350
Crane NXT
CXT
$3.01B
| $1.99M | ﹤0.01% |
97,765
+8,925
| +10% | +$190K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.